Legal Representation
Attorney
Mary Frances Love
USPTO Deadlines
Application History
27 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Jul 22, 2024 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
Jul 22, 2024 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
Dec 19, 2023 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
Oct 24, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Oct 24, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
Oct 4, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
Sep 19, 2023 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Aug 22, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Aug 22, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Aug 21, 2023 | ALIE | A | ASSIGNED TO LIE | Loading... |
Apr 7, 2023 | ERFR | I | TEAS REQUEST FOR RECONSIDERATION RECEIVED | Loading... |
Oct 7, 2022 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
Oct 7, 2022 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
Oct 7, 2022 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
Jul 11, 2022 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Jun 30, 2022 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Jun 30, 2022 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Jun 30, 2022 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
Dec 30, 2021 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
Dec 30, 2021 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
Dec 30, 2021 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Dec 17, 2021 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Aug 5, 2021 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
Aug 5, 2021 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
Aug 5, 2021 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
Aug 3, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Apr 30, 2021 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical agents for the treatment of disorders of the metabolism and digestive system; pharmaceutical agents for the treatment of lysosomal storage disorders and lysosomal storage diseases; pharmaceutical agents for the treatment of lysosomal storage disorders and lysosomal storage diseases all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; pharmaceutical agents for the treatment of Wilson's Disease; pharmaceutical agents for the treatment of Wilson's Disease, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; pharmaceutical preparations for the treatment of disorders of the metabolism and digestive system; pharmaceutical preparations for the treatment of lysosomal storage disorders and lysosomal storage diseases; pharmaceutical preparations for the treatment of lysosomal storage disorders and lysosomal storage diseases, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; pharmaceutical preparations for the treatment of Wilson's Disease; pharmaceutical preparations for the treatment of Wilson's Disease, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; pharmaceuticals for the treatment of disorders of the metabolism and digestive system, pharmaceuticals for the treatment of lysosomal storage disorders and lysosomal storage diseases; pharmaceuticals for the treatment of lysosomal storage disorders and lysosomal storage diseases, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; pharmaceuticals for the treatment of Wilson's Disease; pharmaceuticals for the treatment of Wilson's Disease, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; Veterinary pharmaceutical preparations for treatment of disorders of the metabolism and digestive system; veterinary pharmaceutical preparations, namely, antioxidants; Veterinary pharmaceutical preparations, namely, pain relief medications; Veterinary pharmaceutical preparations for treatment of chronic illnesses; Veterinary pharmaceutical preparations for treatment of viral diseases; sanitary preparations for medical purposes; dietetic foods adapted for medical or veterinary use; dietary supplements for humans and animals supplements for the treatment of disorders of the metabolism and digestive system; Dietary supplements for the treatment of lysosomal storage disorders and lysosomal storage diseases, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibles, vapors, gases, mists, creams, gels and patches; Dietary supplements for the treatment of Wilson's Disease, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; food for babies; medical dressings; plasters for medical purposes; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides; biological preparations for the treatment of disorders of the metabolism and digestive system; biological preparations for the treatment of lysosomal storage disorders and lysosomal storage diseases, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; biological preparations for the treatment of Wilson's Disease, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; chemical preparations for medical purposes, namely, for the treatment of disorders of the metabolism and digestive system; chemical preparations for medical purposes, namely, for the treatment of lysosomal storage disorders and lysosomal storage diseases, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibles, vapors, gases, mists, creams, gels and patches; chemical preparations for medical purposes, namely, for the treatment of Wilson's Disease, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; drug delivery agents in the form of capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches for use in pharmaceuticals; drug delivery agents in the form of capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches for use in the treatment of disorders of the metabolism and digestive system; drug delivery agents in the form of capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches for use in the treatment of lysosomal storage disorders and lysosomal storage diseases; drug delivery agents in the form of capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches for use in the treatment of Wilson's Disease; Pharmaceutical preparations in the form of drugs and medicines for the treatment of disorders of the metabolism and digestive system; Pharmaceutical preparations in the form drugs and medicines for the treatment of lysosomal storage disorders and lysosomal storage diseases, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibles, vapors, gases, mists, creams, gels and patches; Pharmaceutical preparations in the form drugs and medicines for the treatment of Wilson's Disease, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; Pharmaceutical preparations in the form of drugs for the treatment of rare diseases, in particular for the treatment of disorders of the metabolism and digestive system; Pharmaceutical preparations in the form of drugs for the treatment of rare diseases, in particular for the treatment of lysosomal storage disorders and lysosomal storage diseases, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; Pharmaceutical preparations in the form of drugs for the treatment of rare diseases, in particular for Wilson's Disease, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibles, vapors, gases, mists, creams, gels and patches; enzyme preparations for medical purposes; enzyme preparations for medical purposes for the treatment of disorders of the metabolism and digestive system; enzyme preparations for medical purposes the treatment of lysosomal storage disorders and lysosomal storage diseases; enzyme preparations for medical purposes the treatment of Wilson's Disease; medical enzyme preparations for medical purposes in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; enzyme preparations for veterinary purposes; medical preparations for the treatment of disorders of the metabolism and digestive systems; medical preparations for the treatment of lysosomal storage disorders and lysosomal storage diseases, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; medical preparations for the treatment of Wilson's Disease, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; medical preparations for the treatment of disorders of the metabolism and digestive system, medicines for the treatment of lysosomal storage disorders and lysosomal storage diseases, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches medicines for the treatment of Wilson's Disease, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches
Additional Information
Translation
The wording "LUXZYLA" has no meaning in a foreign language.
Classification
International Classes
005